Location：Home /  Resource
Past list
Data performance of tumor sample sequencing on DNBSEQ-T7
Release date：2021-07-01Writer：MGIViews：2507Share

Powered by MGI's unique DNBSEQTM Technology, DNBSEQ-T7, fully upgrading biochemical, fluidics, and optical systems, makes sequencing more efficient and productive. At our upcoming webinar, we will introduce the low-frequency variants detection of DNBSEQ-T7 platform in particular. Also, by comparing the platforms between DNSBEQ platform and other sequencing platforms, you will gain more knowledge of DNBSEQ-T7 platform based on research data, which includes:

  • Outstanding advantages of DNBSEQ-T7 platform for somatic SNVs and indels.
  • The potential applicability of DNBSEQ-T7 platform in actual genome analysis fields.




Prev：Massively Parallel Sequencing for SARS-CoV-2 Detection and SurveillanceNext：COVID-19 Webinar Series: The use of MGI sequencing platform in a translational response against COVID-19
Sol A Jeon
Sol A Jeon
University of Science & Technology & KIRBB


If you have any questions, you can send an email to:
  • Hotline (Global)
    +86-4000-688-114
  • Email
    MGI-service@mgi-tech.com
  • Special Recommendations
    MGI Japan
    MGI North America
    MGI Europe and Africa

  • *For research use only.

    Not for use in diagnostic procedures (except as specifically noted).
Copyright © 2024 All Rights Reserved MGI Tech Co., Ltd. Guangdong ICP 16117185Privacy PolicyLegal NoticesCookie Policy
Our use of cookies
We would like to use necessary cookies to improve your browsing experience and the quality of our website. We would also like to set analytics cookies and advertisement cookies that help us make improvements by measuring how you use our website. Detailed information about the use of cookies on this website and how you can control your consent can be found in our Cookie Policy and Privacy Policy.
Accept only strictly necessary cookiesAccept all cookies